Searching News Database: urinary incontinence
HSMN NewsFeed - 22 Jul 2022
Published Studies Find Low Documented Adherence to Guideline-Based Care for Female Urinary Incontinence
Published Studies Find Low Documented Adherence to Guideline-Based Care for Female Urinary Incontinence
HSMN NewsFeed - 9 May 2022
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
HSMN NewsFeed - 18 Feb 2021
Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim(TM) SureScan(TM) MRI Leads
Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim(TM) SureScan(TM) MRI Leads
HSMN NewsFeed - 6 Oct 2020
Medtronic Announces First Patient Implanted in ELITE Study of InterStim(TM) Micro
Medtronic Announces First Patient Implanted in ELITE Study of InterStim(TM) Micro
HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
HSMN NewsFeed - 20 Apr 2017
Ash Keswani Joins Cogentix Medical as SVP of Marketing and Business Development
Ash Keswani Joins Cogentix Medical as SVP of Marketing and Business Development
HSMN NewsFeed - 13 Oct 2015
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
HSMN NewsFeed - 30 Jul 2015
Japanese Approval Trial for Stress Urinary Incontinence Using Cytori Cell Therapy Announced
Japanese Approval Trial for Stress Urinary Incontinence Using Cytori Cell Therapy Announced
HSMN NewsFeed - 23 Apr 2015
Coloplast Titan(R) Inflatable Penile Prosthesis Approved for Ectopic Placement
Coloplast Titan(R) Inflatable Penile Prosthesis Approved for Ectopic Placement
HSMN NewsFeed - 24 Feb 2015
Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Cigna
Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Cigna
HSMN NewsFeed - 10 Nov 2014
NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate
NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate
HSMN NewsFeed - 5 Nov 2014
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology
HSMN NewsFeed - 29 Oct 2013
Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Humana, Inc.
Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Humana, Inc.
HSMN NewsFeed - 24 Sep 2013
First U.S. Patient Treated Following FDA Clearance of NeoTract's UroLift(R) System
First U.S. Patient Treated Following FDA Clearance of NeoTract's UroLift(R) System
HSMN NewsFeed - 7 Sep 2012
Mylan Announces Settlement Agreement in Litigation Relating to Detrol(R) LA
Mylan Announces Settlement Agreement in Litigation Relating to Detrol(R) LA
HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
HSMN NewsFeed - 1 Mar 2012
Medical Breakthrough for Incontinence From InControl Medical, LLC Cleared by FDA
Medical Breakthrough for Incontinence From InControl Medical, LLC Cleared by FDA
HSMN NewsFeed - 8 Dec 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
HSMN NewsFeed - 11 Jul 2011
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
HSMN NewsFeed - 29 Oct 2010
Coloplast Acquires Mpathy Medical and Strengthens the Company's Position Within Female Pelvic Health
Coloplast Acquires Mpathy Medical and Strengthens the Company's Position Within Female Pelvic Health
HSMN NewsFeed - 28 Jun 2010
American Medical Systems Announces FDA Clearance for MiniArc(R) Precise Single-Incision Sling
American Medical Systems Announces FDA Clearance for MiniArc(R) Precise Single-Incision Sling
HSMN NewsFeed - 8 Sep 2009
American Medical Systems Expands Gold-Standard AMS 800(R) Artificial Urinary Sphincter Line
American Medical Systems Expands Gold-Standard AMS 800(R) Artificial Urinary Sphincter Line
HSMN NewsFeed - 22 Apr 2009
Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria
Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria
HSMN NewsFeed - 12 Mar 2009
GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery
GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery
HSMN NewsFeed - 24 Feb 2009
Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women
Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women
HSMN NewsFeed - 27 Jan 2009
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
HSMN NewsFeed - 3 Nov 2008
Misonix Announces New Distribution Agreement for the United Kingdom and Ireland
Misonix Announces New Distribution Agreement for the United Kingdom and Ireland
HSMN NewsFeed - 31 Oct 2008
Pfizer's TOVIAZ(TM) (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder
Pfizer's TOVIAZ(TM) (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder
HSMN NewsFeed - 8 Sep 2008
MediciNova to Present At Merriman Curhan Ford's 5th Annual Investor Summit 2008
MediciNova to Present At Merriman Curhan Ford's 5th Annual Investor Summit 2008
HSMN NewsFeed - 28 Aug 2008
New Treatment Launched to Help Improve Symptoms in People Suffering From Overactive Bladder
New Treatment Launched to Help Improve Symptoms in People Suffering From Overactive Bladder
HSMN NewsFeed - 22 Aug 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
HSMN NewsFeed - 27 Jun 2008
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
HSMN NewsFeed - 22 May 2008
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
HSMN NewsFeed - 21 May 2008
Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
HSMN NewsFeed - 25 Mar 2008
Large Study Reports That 65% of Male Patients with Stress Urinary Incontinence Were Dry at Two Years
Large Study Reports That 65% of Male Patients with Stress Urinary Incontinence Were Dry at Two Years
HSMN NewsFeed - 1 Feb 2008
MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
HSMN NewsFeed - 26 Nov 2007
Beijing Med-Pharm Announces Exclusive Agreement to Market Enablex(R) in China
Beijing Med-Pharm Announces Exclusive Agreement to Market Enablex(R) in China
HSMN NewsFeed - 15 Nov 2007
Coloplast A/S Acquires Levera Male Incontinence Therapy from Caldera Medical
Coloplast A/S Acquires Levera Male Incontinence Therapy from Caldera Medical
HSMN NewsFeed - 9 Nov 2007
New Data Presented on the Renessa(R) Treatment for Female Stress Urinary Incontinence
New Data Presented on the Renessa(R) Treatment for Female Stress Urinary Incontinence
HSMN NewsFeed - 8 Oct 2007
Clinical Study of American Medical Systems' Female Stress Urinary Incontinence Product Wins Top Honors
Clinical Study of American Medical Systems' Female Stress Urinary Incontinence Product Wins Top Honors
HSMN NewsFeed - 24 Sep 2007
Tri-anim Announces a New Name for Neomedic's Family of Urinary Stress Incontinence Products
Tri-anim Announces a New Name for Neomedic's Family of Urinary Stress Incontinence Products
HSMN NewsFeed - 23 Aug 2007
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
HSMN NewsFeed - 25 Jul 2007
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
HSMN NewsFeed - 3 Jul 2007
BioForm Strengthens Management Team With Three Leading Industry Executives
BioForm Strengthens Management Team With Three Leading Industry Executives
HSMN NewsFeed - 26 Jun 2007
Cook Medical Introduces Device to Naturally Prepare Pregnant Women for Labor Induction
Cook Medical Introduces Device to Naturally Prepare Pregnant Women for Labor Induction
HSMN NewsFeed - 17 May 2007
Coloplast Corp. Announces Exclusive U.S. Distribution of the Durasphere(R) EXP Bulking Agent
Coloplast Corp. Announces Exclusive U.S. Distribution of the Durasphere(R) EXP Bulking Agent
HSMN NewsFeed - 16 May 2007
Tri-anim Releases Remeex(TM) Male Adjustable Sling System for Incontinence at AUA
Tri-anim Releases Remeex(TM) Male Adjustable Sling System for Incontinence at AUA
HSMN NewsFeed - 9 May 2007
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
HSMN NewsFeed - 30 Apr 2007
Tri-anim Releases Remeex(TM) Needleless(TM) Sling System for Female Incontinence at ACOG
Tri-anim Releases Remeex(TM) Needleless(TM) Sling System for Female Incontinence at ACOG
HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
HSMN NewsFeed - 10 Apr 2007
Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists
Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists
HSMN NewsFeed - 27 Mar 2007
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
HSMN NewsFeed - 12 Mar 2007
New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
HSMN NewsFeed - 20 Feb 2007
Bakri Postpartum Balloon Globally Acknowledged for Treatment of Postpartum Bleeding
Bakri Postpartum Balloon Globally Acknowledged for Treatment of Postpartum Bleeding
HSMN NewsFeed - 7 Dec 2006
HRA Pharma Commences US Phase III Trial of Second-Generation Emergency Contraceptive
HRA Pharma Commences US Phase III Trial of Second-Generation Emergency Contraceptive
HSMN NewsFeed - 4 Dec 2006
Uroplasty, Inc. Announces Distribution Agreement for EasyCont P/Q(TM) Incontinence Diagnostic Device
Uroplasty, Inc. Announces Distribution Agreement for EasyCont P/Q(TM) Incontinence Diagnostic Device
HSMN NewsFeed - 27 Nov 2006
Uroplasty, Inc. Appoints Steve Bowers as National Business Development Manager - Pelvic Floor
Uroplasty, Inc. Appoints Steve Bowers as National Business Development Manager - Pelvic Floor
HSMN NewsFeed - 10 Nov 2006
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
HSMN NewsFeed - 6 Nov 2006
Indevus Announces Licensing and Manufacturing Pact for SANCTURA XR(TM) With Madaus GmbH
Indevus Announces Licensing and Manufacturing Pact for SANCTURA XR(TM) With Madaus GmbH
HSMN NewsFeed - 1 Nov 2006
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
HSMN NewsFeed - 6 Oct 2006
FDA Approves RISPERDAL(R) for Treatment of Irritability Associated with Autistic Disorder
FDA Approves RISPERDAL(R) for Treatment of Irritability Associated with Autistic Disorder
HSMN NewsFeed - 12 Sep 2006
Q-Med: Q-Med's First Product in the Field of Body Augmentations, MACROLANE, Approved in Europe
Q-Med: Q-Med's First Product in the Field of Body Augmentations, MACROLANE, Approved in Europe
HSMN NewsFeed - 7 Sep 2006
IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
HSMN NewsFeed - 11 Jul 2006
Uroplasty Initiates Clinical Study Comparing Urgent(R) PC to Drug Therapy for Overactive Bladder Treatment
Uroplasty Initiates Clinical Study Comparing Urgent(R) PC to Drug Therapy for Overactive Bladder Treatment
HSMN NewsFeed - 7 Jul 2006
Indevus Announces Positive Data from Second Phase III Trial for SANCTURA XR(TM) in Overactive Bladder
Indevus Announces Positive Data from Second Phase III Trial for SANCTURA XR(TM) in Overactive Bladder
HSMN NewsFeed - 5 Jul 2006
Uroplasty, Inc. Announces FDA Clearance for Their Next-Generation Device to Treat Overactive Bladder
Uroplasty, Inc. Announces FDA Clearance for Their Next-Generation Device to Treat Overactive Bladder
HSMN NewsFeed - 28 Jun 2006
Smith & Nephew and Q-MED Enter Into Strategic Alliance in Osteoarthritis Treatment
Smith & Nephew and Q-MED Enter Into Strategic Alliance in Osteoarthritis Treatment
HSMN NewsFeed - 21 Jun 2006
Uroplasty's Next-Generation Device to Treat Overactive Bladder Awarded CE Marking
Uroplasty's Next-Generation Device to Treat Overactive Bladder Awarded CE Marking
HSMN NewsFeed - 24 May 2006
Clinical Trial Tests Effect of Ultrasound Waves on Early-Stage Prostate Cancer
Clinical Trial Tests Effect of Ultrasound Waves on Early-Stage Prostate Cancer
HSMN NewsFeed - 18 May 2006
Uroplasty, Inc. Announces Appointment of New President and Chief Executive Officer
Uroplasty, Inc. Announces Appointment of New President and Chief Executive Officer
HSMN NewsFeed - 11 May 2006
ETHICON Announces CE Mark Approval of New Device to Treat Female Stress Incontinence
ETHICON Announces CE Mark Approval of New Device to Treat Female Stress Incontinence
HSMN NewsFeed - 10 May 2006
Boston Scientific and BioForm Medical Announce FDA Approval of Coaptite(R) Injectable Implant
Boston Scientific and BioForm Medical Announce FDA Approval of Coaptite(R) Injectable Implant
HSMN NewsFeed - 8 May 2006
Cook Launches Women's Health Business Unit To Increase Quality of Life for Female Patients
Cook Launches Women's Health Business Unit To Increase Quality of Life for Female Patients
Additional items found! 166
Members Archive contains
166 additional stories matching:
urinary incontinence
(Password required)
urinary incontinence
(Password required)